Lazari Capital Management’s Pfizer PFE Stock Holding History

Lazari Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.55M	Sell	64,489 -916	-1%	-$24K	0.48%	38
2026 Q1	$1.84M	Sell	65,405 -2,865	-4%	-$76.3K	0.64%	31
2025 Q4	$1.7M	Buy	68,270 +931	+1%	+$23.5K	0.57%	32
2025 Q3	$1.72M	Sell	67,339 -6,961	-9%	-$172K	0.58%	31
2025 Q2	$1.8M	Buy	74,300 +11,920	+19%	+$278K	0.68%	29
2025 Q1	$1.58M	Buy	62,380 +30,151	+94%	+$789K	0.65%	31
2024 Q4	$855K	Buy	32,229 +10,005	+45%	+$271K	0.34%	47
2024 Q3	$643K	Buy	22,224 +3,329	+18%	+$97.1K	0.28%	65
2024 Q2	$529K	Buy	18,895 +536	+3%	+$14.8K	0.24%	71
2024 Q1	$509K	Buy	18,359 +10	+0.1%	+$277	0.28%	60
2023 Q4	$528K	Sell	18,349 -1,000	-5%	-$30.2K	0.3%	58
2023 Q3	$642K	Sell	19,349 -3,322	-15%	-$117K	0.38%	42
2023 Q2	$832K	Buy	+22,671	New	+$882K	0.47%	39

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Lazari Capital Management's PFE Position: Q2 2026 in Review

Lazari Capital Management reduced its Pfizer (PFE) stake by 1.4% in Q2 2026, selling an estimated $24K and leaving 64,489 shares worth $1.55M. The position accounts for 0.48% of the portfolio, ranked #38.

Lazari Capital Management first reported a position in PFE in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.84M in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Lazari Capital Management held 64,489 shares of Pfizer worth $1.55M as of Q2 2026.
Lazari Capital Management sold 916 Pfizer shares in Q2 2026, an estimated $24K.
Pfizer made up 0.48% of Lazari Capital Management's portfolio in Q2 2026, its #38 holding.
Lazari Capital Management first reported a position in Pfizer in Q2 2023 and has held it in 13 quarters since.
Lazari Capital Management's Pfizer position peaked at $1.84M in Q1 2026.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Lazari Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.